Berry Oncology

company

About

Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis.

  • 11 - 50

Details

Last Funding Type
Series B
Last Funding Money Raised
$99.15M
Industries
Health Care,Medical,Medical Device
Founded date
Jan 1, 2017
Number Of Employee
11 - 50
Operating Status
Active

Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer.

The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$99.15M ¥800M
Berry Oncology has raised a total of $99.15M ¥800M in funding over 2 rounds. Their latest funding was raised on Aug 5, 2021 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Aug 5, 2021 Series B $99.15M 1 Detail
Nov 1, 2017 Series A ¥800M 1 Detail

Investors

Number of Lead Investors
Number of Investors
2
Berry Oncology is funded by 2 investors. Zhongjinqichen (Suzhou) Emerging Industry Equity Investment Fund and Hongling Equity Investment Management are the most recent investors.
Investor Name Lead Investor Funding Round
Zhongjinqichen (Suzhou) Emerging Industry Equity Investment Fund Series B
Hongling Equity Investment Management Series A